• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4617939)   Today's Articles (15)   Subscriber (49401)
For: Kinney RM, Huang CY. Development of new vaccines against dengue fever and Japanese encephalitis. Intervirology 2002;44:176-97. [PMID: 11509879 DOI: 10.1159/000050045] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]  Open
Number Cited by Other Article(s)
1
Sasmal SK, Dong Y, Takeuchi Y. Mathematical modeling on T-cell mediated adaptive immunity in primary dengue infections. J Theor Biol 2017;429:229-240. [DOI: 10.1016/j.jtbi.2017.06.035] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2017] [Revised: 06/25/2017] [Accepted: 06/27/2017] [Indexed: 10/19/2022]
2
Dietrich EA, Ong YT, Stovall JL, Dean H, Huang CYH. Limited Transmission Potential of Takeda's Tetravalent Dengue Vaccine Candidate by Aedes albopictus. Am J Trop Med Hyg 2017;97:1423-1427. [PMID: 28820715 DOI: 10.4269/ajtmh.17-0185] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]  Open
3
Schiøler KL, McCarty CW. Vaccines for preventing dengue infection. Hippokratia 2016. [DOI: 10.1002/14651858.cd004613.pub2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
4
Halstead SB, Aguiar M. Dengue vaccines: Are they safe for travelers? Travel Med Infect Dis 2016;14:378-83. [PMID: 27343438 DOI: 10.1016/j.tmaid.2016.06.005] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2016] [Revised: 06/16/2016] [Accepted: 06/17/2016] [Indexed: 10/21/2022]
5
Gonçalves AJS, Oliveira ERA, Costa SM, Paes MV, Silva JFA, Azevedo AS, Mantuano-Barradas M, Nogueira ACMA, Almeida CJ, Alves AMB. Cooperation between CD4+ T Cells and Humoral Immunity Is Critical for Protection against Dengue Using a DNA Vaccine Based on the NS1 Antigen. PLoS Negl Trop Dis 2015;9:e0004277. [PMID: 26650916 PMCID: PMC4674122 DOI: 10.1371/journal.pntd.0004277] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2014] [Accepted: 11/12/2015] [Indexed: 11/19/2022]  Open
6
Fernandez S, Thomas SJ, De La Barrera R, Im-erbsin R, Jarman RG, Baras B, Toussaint JF, Mossman S, Innis BL, Schmidt A, Malice MP, Festraets P, Warter L, Putnak JR, Eckels KH. An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaques. Am J Trop Med Hyg 2015;92:698-708. [PMID: 25646261 PMCID: PMC4385761 DOI: 10.4269/ajtmh.14-0268] [Citation(s) in RCA: 45] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2014] [Accepted: 12/04/2014] [Indexed: 11/07/2022]  Open
7
Guzmán MG, Muné M, Kourí G. Dengue vaccine: priorities and progress. Expert Rev Anti Infect Ther 2014;2:895-911. [PMID: 15566333 DOI: 10.1586/14789072.2.6.895] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
8
Gujarati TP, Ambika G. Virus antibody dynamics in primary and secondary dengue infections. J Math Biol 2014;69:1773-800. [PMID: 24384697 DOI: 10.1007/s00285-013-0749-4] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2012] [Revised: 10/12/2013] [Indexed: 11/26/2022]
9
Pérez-Guerra CL, Rodríguez-Acosta RL, Soto-Gómez E, Zielinski-Gutierrez E, Peña-Orellana M, Santiago LM, Rivera R, Cruz RR, Ramírez V, Tomashek KM, Dayan G. Assessing the interest to participate in a dengue vaccine efficacy trial among residents of Puerto Rico. Hum Vaccin Immunother 2012;8:905-15. [PMID: 22832259 DOI: 10.4161/hv.20056] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]  Open
10
Osorio JE, Huang CYH, Kinney RM, Stinchcomb DT. Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever. Vaccine 2011;29:7251-60. [PMID: 21777638 PMCID: PMC4592106 DOI: 10.1016/j.vaccine.2011.07.020] [Citation(s) in RCA: 109] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2011] [Revised: 06/25/2011] [Accepted: 07/06/2011] [Indexed: 12/21/2022]
11
Osorio JE, Brewoo JN, Silengo SJ, Arguello J, Moldovan IR, Tary-Lehmann M, Powell TD, Livengood JA, Kinney RM, Huang CYH, Stinchcomb DT. Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaques. Am J Trop Med Hyg 2011;84:978-87. [PMID: 21633037 DOI: 10.4269/ajtmh.2011.10-0592] [Citation(s) in RCA: 80] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]  Open
12
Azevedo AS, Yamamura AMY, Freire MS, Trindade GF, Bonaldo M, Galler R, Alves AMB. DNA vaccines against dengue virus type 2 based on truncate envelope protein or its domain III. PLoS One 2011;6:e20528. [PMID: 21779317 PMCID: PMC3136928 DOI: 10.1371/journal.pone.0020528] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2011] [Accepted: 05/03/2011] [Indexed: 01/18/2023]  Open
13
Venkatesan G, Balamuruga V, Gandhale P, Singh R, Bhanupraka V. Viral Zoonosis: A Comprehensive Review. ACTA ACUST UNITED AC 2010. [DOI: 10.3923/ajava.2010.77.92] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
14
Jalsa NK, Singh G. A unique approach to the synthesis of a dengue vaccine and the novel tetrasaccharide that results. ACTA ACUST UNITED AC 2009. [DOI: 10.1016/j.tetasy.2009.02.024] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
15
Supriatna A, Soewono E, van Gils S. A two-age-classes dengue transmission model. Math Biosci 2008;216:114-21. [DOI: 10.1016/j.mbs.2008.08.011] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2007] [Revised: 08/20/2008] [Accepted: 08/21/2008] [Indexed: 11/25/2022]
16
Ward R, Davidson AD. Reverse genetics and the study of dengue virus. Future Virol 2008. [DOI: 10.2217/17460794.3.3.279] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
17
Mustafa MS, Agrawal VK. Dengue Vaccine: The Current Status. Med J Armed Forces India 2008;64:161-4. [PMID: 27408122 PMCID: PMC4921523 DOI: 10.1016/s0377-1237(08)80065-2] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2007] [Accepted: 11/06/2007] [Indexed: 12/18/2022]  Open
18
Amexis G, Young NS. Multiple antigenic peptides as vaccine platform for the induction of humoral responses against dengue-2 virus. Viral Immunol 2008;20:657-63. [PMID: 18158738 DOI: 10.1089/vim.2007.0029] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]  Open
19
Sim ACN, Lin W, Tan GKX, Sim MST, Chow VTK, Alonso S. Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen. Vaccine 2008;26:1145-54. [PMID: 18243432 DOI: 10.1016/j.vaccine.2007.12.047] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2007] [Revised: 12/04/2007] [Accepted: 12/28/2007] [Indexed: 01/12/2023]
20
Dengue vaccines. Vaccines (Basel) 2008. [DOI: 10.1016/b978-1-4160-3611-1.50047-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
21
Chen S, Yu M, Jiang T, Deng Y, Qin C, Qin E. Induction of tetravalent protective immunity against four dengue serotypes by the tandem domain III of the envelope protein. DNA Cell Biol 2007;26:361-7. [PMID: 17570760 DOI: 10.1089/dna.2006.0547] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
22
Costa SM, Azevedo AS, Paes MV, Sarges FS, Freire MS, Alves AMB. DNA vaccines against dengue virus based on the ns1 gene: The influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice. Virology 2007;358:413-23. [PMID: 17020777 DOI: 10.1016/j.virol.2006.08.052] [Citation(s) in RCA: 61] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2006] [Revised: 08/21/2006] [Accepted: 08/30/2006] [Indexed: 11/23/2022]
23
Apt D, Raviprakash K, Brinkman A, Semyonov A, Yang S, Skinner C, Diehl L, Lyons R, Porter K, Punnonen J. Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen. Vaccine 2006;24:335-44. [PMID: 16125280 DOI: 10.1016/j.vaccine.2005.07.100] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2005] [Accepted: 07/28/2005] [Indexed: 10/25/2022]
24
Pugachev KV, Guirakhoo F, Monath TP. New developments in flavivirus vaccines with special attention to yellow fever. Curr Opin Infect Dis 2005;18:387-94. [PMID: 16148524 DOI: 10.1097/01.qco.0000178823.28585.ad] [Citation(s) in RCA: 70] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
25
Huang CYH, Silengo SJ, Whiteman MC, Kinney RM. Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus. J Virol 2005;79:7300-10. [PMID: 15919884 PMCID: PMC1143654 DOI: 10.1128/jvi.79.12.7300-7310.2005] [Citation(s) in RCA: 45] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]  Open
26
Mota J, Acosta M, Argotte R, Figueroa R, Méndez A, Ramos C. Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein. Vaccine 2005;23:3469-76. [PMID: 15837370 DOI: 10.1016/j.vaccine.2004.12.028] [Citation(s) in RCA: 59] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2004] [Revised: 12/20/2004] [Accepted: 12/21/2004] [Indexed: 11/30/2022]
27
Warda M, Linhardt RJ, Marks RM. Patents related to dengue virus infection. Expert Opin Ther Pat 2005. [DOI: 10.1517/13543776.12.8.1127] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
28
Mackenzie JS, Gubler DJ, Petersen LR. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 2005;10:S98-109. [PMID: 15577938 DOI: 10.1038/nm1144] [Citation(s) in RCA: 858] [Impact Index Per Article: 45.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
29
Chang GJJ, Kuno G, Purdy DE, Davis BS. Recent advancement in flavivirus vaccine development. Expert Rev Vaccines 2004;3:199-220. [PMID: 15056045 DOI: 10.1586/14760584.3.2.199] [Citation(s) in RCA: 47] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
30
Mutoh E, Ishikawa T, Takamizawa A, Kurata T, Sata T, Kojima A. Japanese encephalitis subunit vaccine composed of virus-like envelope antigen particles purified from serum-free medium of a high-producer J12#26 cell clone. Vaccine 2004;22:2599-608. [PMID: 15193385 DOI: 10.1016/j.vaccine.2003.12.008] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2003] [Revised: 11/26/2003] [Accepted: 12/11/2003] [Indexed: 11/28/2022]
31
Shepard DS, Suaya JA, Halstead SB, Nathan MB, Gubler DJ, Mahoney RT, Wang DNC, Meltzer MI. Cost-effectiveness of a pediatric dengue vaccine. Vaccine 2004;22:1275-80. [PMID: 15003657 DOI: 10.1016/j.vaccine.2003.09.019] [Citation(s) in RCA: 105] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2003] [Revised: 07/14/2003] [Accepted: 09/03/2003] [Indexed: 11/25/2022]
32
Eckels KH, Putnak R. Formalin-inactivated whole virus and recombinant subunit flavivirus vaccines. Adv Virus Res 2004;61:395-418. [PMID: 14714438 DOI: 10.1016/s0065-3527(03)61010-9] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
33
Damonte EB, Pujol CA, Coto CE. Prospects for the Therapy and Prevention of Dengue Virus Infections. Adv Virus Res 2004;63:239-85. [PMID: 15530563 DOI: 10.1016/s0065-3527(04)63004-1] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
34
Huang CYH, Butrapet S, Tsuchiya KR, Bhamarapravati N, Gubler DJ, Kinney RM. Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development. J Virol 2003;77:11436-47. [PMID: 14557629 PMCID: PMC229366 DOI: 10.1128/jvi.77.21.11436-11447.2003] [Citation(s) in RCA: 144] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
35
DeRoeck D, Deen J, Clemens JD. Policymakers’ views on dengue fever/dengue haemorrhagic fever and the need for dengue vaccines in four southeast Asian countries. Vaccine 2003;22:121-9. [PMID: 14604579 DOI: 10.1016/s0264-410x(03)00533-4] [Citation(s) in RCA: 56] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
36
Konishi E, Terazawa A, Fujii A. Evidence for antigen production in muscles by dengue and Japanese encephalitis DNA vaccines and a relation to their immunogenicity in mice. Vaccine 2003;21:3713-20. [PMID: 12922102 DOI: 10.1016/s0264-410x(03)00376-1] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
37
Kojima A, Yasuda A, Asanuma H, Ishikawa T, Takamizawa A, Yasui K, Kurata T. Stable high-producer cell clone expressing virus-like particles of the Japanese encephalitis virus e protein for a second-generation subunit vaccine. J Virol 2003;77:8745-55. [PMID: 12885894 PMCID: PMC167253 DOI: 10.1128/jvi.77.16.8745-8755.2003] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
38
Han SZ, Alfano MC, Psoter WJ, Rekow ED. Bioterrorism and catastrophe response: a quick-reference guide to resources. J Am Dent Assoc 2003;134:745-52. [PMID: 12839411 DOI: 10.14219/jada.archive.2003.0261] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
39
Pang T. Vaccines for the prevention of neglected diseases--dengue fever. Curr Opin Biotechnol 2003;14:332-6. [PMID: 12849789 DOI: 10.1016/s0958-1669(03)00061-2] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
40
Pugachev KV, Guirakhoo F, Trent DW, Monath TP. Traditional and novel approaches to flavivirus vaccines. Int J Parasitol 2003;33:567-82. [PMID: 12782056 DOI: 10.1016/s0020-7519(03)00063-8] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
41
Lai CJ, Monath TP. Chimeric Flaviviruses: Novel Vaccines against Dengue Fever, Tick-borne Encephalitis, and Japanese Encephalitis. Adv Virus Res 2003;61:469-509. [PMID: 14714441 DOI: 10.1016/s0065-3527(03)61013-4] [Citation(s) in RCA: 77] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
42
Halstead SB, Deen J. The future of dengue vaccines. Lancet 2002;360:1243-5. [PMID: 12401270 DOI: 10.1016/s0140-6736(02)11276-1] [Citation(s) in RCA: 98] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
43
Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 2002;10:100-3. [PMID: 11827812 DOI: 10.1016/s0966-842x(01)02288-0] [Citation(s) in RCA: 875] [Impact Index Per Article: 39.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA